Annual Shareholders Equity
$46.23 M
-$24.68 M-34.81%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual stockholders equity is currently $46.23 million, with the most recent change of -$24.68 million (-34.81%) on 31 December 2022. During the last 3 years, it has fallen by -$13.91 million (-23.14%).ZYNE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$29.02 M
-$9.95 M-25.52%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly stockholders equity is currently $29.02 million, with the most recent change of -$9.95 million (-25.52%) on 30 June 2023.ZYNE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -23.1% | -63.1% |
| 5 y5 years | -19.7% | -65.9% |
ZYNE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -38.8% | -69.7% |
Zynerba Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $29.02 M(-25.5%) |
| Mar 2023 | - | $38.97 M(-15.7%) |
| Dec 2022 | $46.23 M(-34.8%) | $46.23 M(-12.4%) |
| Sept 2022 | - | $52.76 M(-7.8%) |
| June 2022 | - | $57.24 M(-12.2%) |
| Mar 2022 | - | $65.17 M(-8.1%) |
| Dec 2021 | $70.91 M(+17.9%) | $70.91 M(-9.9%) |
| Sept 2021 | - | $78.69 M(-10.3%) |
| June 2021 | - | $87.70 M(-8.4%) |
| Mar 2021 | - | $95.72 M(+59.1%) |
| Dec 2020 | $60.14 M(-20.4%) | $60.14 M(-9.7%) |
| Sept 2020 | - | $66.64 M(-10.5%) |
| June 2020 | - | $74.43 M(+12.5%) |
| Mar 2020 | - | $66.16 M(-12.5%) |
| Dec 2019 | $75.60 M(+31.2%) | $75.60 M(-11.1%) |
| Sept 2019 | - | $85.01 M(-0.7%) |
| June 2019 | - | $85.58 M(+25.8%) |
| Mar 2019 | - | $68.03 M(+18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $57.60 M(-5.5%) | $57.60 M(-9.7%) |
| Sept 2018 | - | $63.79 M(+59.2%) |
| June 2018 | - | $40.08 M(-20.4%) |
| Mar 2018 | - | $50.33 M(-17.4%) |
| Dec 2017 | $60.95 M(+106.0%) | $60.95 M(-5.7%) |
| Sept 2017 | - | $64.64 M(-9.2%) |
| June 2017 | - | $71.23 M(-8.4%) |
| Mar 2017 | - | $77.76 M(+162.8%) |
| Dec 2016 | $29.59 M(-25.5%) | $29.59 M(-4.2%) |
| Sept 2016 | - | $30.88 M(+0.4%) |
| June 2016 | - | $30.77 M(-15.0%) |
| Mar 2016 | - | $36.19 M(-8.9%) |
| Dec 2015 | $39.71 M(-593.1%) | $39.71 M(-10.5%) |
| Sept 2015 | - | $44.38 M(-497.3%) |
| June 2015 | - | -$11.17 M(-260.0%) |
| Mar 2015 | - | $6.98 M(-186.7%) |
| Dec 2014 | -$8.05 M(+572.8%) | -$8.05 M |
| Dec 2013 | -$1.20 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ZYNE is $46.23 M
What is the all time high annual shareholders equity for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual stockholders equity is $75.60 M
What is Zynerba Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ZYNE is $29.02 M
What is the all time high quarterly shareholders equity for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly stockholders equity is $95.72 M